UK markets open in 7 hours 56 minutes

Basilea Pharmaceutica AG (0QNA.L)

LSE - LSE Delayed price. Currency in CHF
Add to watchlist
39.50-0.60 (-1.50%)
At close: 05:02PM BST
Currency in CHF

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-27.97%
S&P500 52-week change 323.10%
52-week high 351.30
52-week low 30.00
50-day moving average 335.23
200-day moving average 339.55

Share statistics

Avg vol (3-month) 34.88k
Avg vol (10-day) 32.97k
Shares outstanding 510.87M
Implied shares outstanding 6N/A
Float 811.63M
% held by insiders 10.06%
% held by institutions 136.99%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 6.63%
Operating margin (ttm)-22.51%

Management effectiveness

Return on assets (ttm)6.95%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)157.63M
Revenue per share (ttm)13.15
Quarterly revenue growth (yoy)-19.30%
Gross profit (ttm)N/A
EBITDA 23.18M
Net income avi to common (ttm)10.45M
Diluted EPS (ttm)-0.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)59.93M
Total cash per share (mrq)4.99
Total debt (mrq)128.61M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.20
Book value per share (mrq)-0.83

Cash flow statement

Operating cash flow (ttm)14.24M
Levered free cash flow (ttm)8.51M